At the request of NRC Region I, Camden-Clark Memorial Hospital reassessed records from a prostate radioactive seed implantation procedure that had been performed on February 25, 2011. The record review indicated that the patient had received roughly 80 percent of the prescribed dose.
The effect on the patient has been minimal as the desired response was achieved. The long term effect will be under constant follow-up.
The entire implant process will be reviewed with special attention to real time seed placement and subsequent thirty day image evaluation with respect to NRC regulatory guidelines.
The attending physician, based on medical judgment, felt that notifying the patient would be harmful. The patient is under the care of oncologic physicians and will be followed appropriately as per his disease type.
- * * UPDATE AT 1636 EST ON 12/03/12 FROM DAN BERKLEY TO S. SANDIN * * *
The licensee is updating the report with the following information:
That (1) the dose received by the target was less than 80% of the prescribed dose and (2) a small volume of tissue outside of, and adjacent to, the treatment site received a dose that was greater than 10 Gy and more than 50% greater than the prescribed dose to that location."
The licensee discussed this update with R1 (Weidner). Notified R1DO (Jackson) and FSME Events Resource via email.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.